Actively Recruiting
Evaluating Noninvasive Spinal Cord Stimulation to Improve Metabolic Function in Adults with and without Spinal Cord Injury
Led by Rahul Sachdeva · Updated on 2026-10-29
120
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of noninvasive transcutaneous spinal cord stimulation tSCS to improve glucose regulation and metabolic function in adults with and without spinal cord injury SCI, including those with normal glucose metabolism, prediabetes, or type 2 diabetes T2D. The study aims to address metabolic dysfunction that affects both SCI individuals and able-bodied people, focusing on safe, noninvasive approaches to target the underlying physiological problems. Participants will be randomly assigned to receive either active tSCS or a sham inactive version of the stimulation device. The study includes six groups based on the presence or absence of SCI and metabolic condition. The effects of tSCS on glucose metabolism will be evaluated both in the short term and over time, with key measurements including glucose and insulin levels during oral glucose tolerance tests OGTT at multiple time points and continuous glucose monitoring over 12 weeks. During the study, participants will undergo several assessments such as OGTTs at weeks 1, 2, 7, 13, and 19, along with continuous glucose monitoring from baseline through 12 weeks. Researchers will collect data on insulin sensitivity and metabolic biomarkers to understand the impact of tSCS. The study will monitor safety and metabolic responses throughout the participation period, which lasts through the study completion in December 2030.
CONDITIONS
Brief Title
Neuromodulation for Metabolic Dysfunction
Research Team
R
Rahul Sachedva, PhD
V
Vivek Pandey, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here